🚀 VC round data is live in beta, check it out!
PureHealth Valuation Multiples
Discover revenue and EBITDA valuation multiples for PureHealth and similar public comparables like Fortis Healthcare, Ramsay Health, PACS Group, RadNet and more.
PureHealth Overview
About PureHealth
Pure Health Holding PJSC is an integrated healthcare company in the United Arab Emirates with a cross-category ecosystem covering hospitals, clinics, diagnostics, insurance, pharmacies, research, health tech, and procurement along with an international footprint in the United States and the United Kingdom. The company's reportable segments are Hospital and Related Services, Health Insurance Services, Procurement and Supply, Diagnostic Services and Technology Services and Others. Key revenue is derived from its Hospitalisation and other related services segment through which it provides general healthcare operations including hospitalization, clinical, isolation/quarantine, vaccinations, and other services.
Founded
2021
HQ
Employees
56.0K
Website
Sectors
Financials (LTM)
EV
$10B
PureHealth Financials
PureHealth reported last 12-month revenue of $8B and EBITDA of $1B.
In the same LTM period, PureHealth generated $2B in gross profit, $1B in EBITDA, and $561M in net income.
Revenue (LTM)
PureHealth P&L
In the most recent fiscal year, PureHealth reported revenue of $7B and EBITDA of $1B.
PureHealth expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $8B | XXX | $7B | XXX | XXX | XXX |
| Gross Profit | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Margin | 21% | XXX | 25% | XXX | XXX | XXX |
| EBITDA | $1B | XXX | $1B | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBIT Margin | 10% | XXX | 11% | XXX | XXX | XXX |
| Net Profit | $561M | XXX | $545M | XXX | XXX | XXX |
| Net Margin | 7% | XXX | 7% | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
PureHealth Stock Performance
PureHealth has current market cap of $7B, and enterprise value of $10B.
Market Cap Evolution
PureHealth's stock price is $0.60.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $10B | $7B | 0.0% | XXX | XXX | XXX | $0.05 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPureHealth Valuation Multiples
PureHealth trades at 1.2x EV/Revenue multiple, and 7.5x EV/EBITDA.
EV / Revenue (LTM)
PureHealth Financial Valuation Multiples
As of April 15, 2026, PureHealth has market cap of $7B and EV of $10B.
Equity research analysts estimate PureHealth's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
PureHealth has a P/E ratio of 11.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $7B | XXX | $7B | XXX | XXX | XXX |
| EV (current) | $10B | XXX | $10B | XXX | XXX | XXX |
| EV/Revenue | 1.2x | XXX | 1.3x | XXX | XXX | XXX |
| EV/EBITDA | 7.5x | XXX | 7.3x | XXX | XXX | XXX |
| EV/EBIT | 12.3x | XXX | 11.9x | XXX | XXX | XXX |
| EV/Gross Profit | 6.0x | XXX | 5.3x | XXX | XXX | XXX |
| P/E | 11.9x | XXX | 12.3x | XXX | XXX | XXX |
| EV/FCF | 17.6x | XXX | 9.4x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified PureHealth Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
PureHealth Margins & Growth Rates
PureHealth's revenue in the last 12 month grew by 15%.
PureHealth's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.
PureHealth's rule of 40 is 32% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
PureHealth's rule of X is 59% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
PureHealth Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 15% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | 17% | XXX | 18% | XXX | XXX | XXX |
| EBITDA Growth | 3% | XXX | (5%) | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 32% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 59% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 17% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
PureHealth Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| PureHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Fortis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Ramsay Health | XXX | XXX | XXX | XXX | XXX | XXX |
| PACS Group | XXX | XXX | XXX | XXX | XXX | XXX |
| RadNet | XXX | XXX | XXX | XXX | XXX | XXX |
| Option Care Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
PureHealth M&A Activity
PureHealth acquired XXX companies to date.
Last acquisition by PureHealth was on XXXXXXXX, XXXXX. PureHealth acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by PureHealth
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPureHealth Investment Activity
PureHealth invested in XXX companies to date.
PureHealth made its latest investment on XXXXXXXX, XXXXX. PureHealth invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by PureHealth
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout PureHealth
| When was PureHealth founded? | PureHealth was founded in 2021. |
| Where is PureHealth headquartered? | PureHealth is headquartered in United Arab Emirates. |
| How many employees does PureHealth have? | As of today, PureHealth has over 56K employees. |
| Is PureHealth publicly listed? | Yes, PureHealth is a public company listed on Abu Dhabi Securities Exchange. |
| What is the stock symbol of PureHealth? | PureHealth trades under PUREHEALTH ticker. |
| When did PureHealth go public? | PureHealth went public in 2023. |
| Who are competitors of PureHealth? | PureHealth main competitors are Fortis Healthcare, Ramsay Health, PACS Group, RadNet. |
| What is the current market cap of PureHealth? | PureHealth's current market cap is $7B. |
| What is the current revenue of PureHealth? | PureHealth's last 12 months revenue is $8B. |
| What is the current revenue growth of PureHealth? | PureHealth revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of PureHealth? | Current revenue multiple of PureHealth is 1.2x. |
| Is PureHealth profitable? | Yes, PureHealth is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of PureHealth? | PureHealth's last 12 months EBITDA is $1B. |
| What is PureHealth's EBITDA margin? | PureHealth's last 12 months EBITDA margin is 17%. |
| What is the current EV/EBITDA multiple of PureHealth? | Current EBITDA multiple of PureHealth is 7.5x. |
| What is the current FCF of PureHealth? | PureHealth's last 12 months FCF is $555M. |
| What is PureHealth's FCF margin? | PureHealth's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of PureHealth? | Current FCF multiple of PureHealth is 17.6x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.